Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines

doi:10.3748/wjg.v9.i6.1302

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3218)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series.

Item

Count

PDF

438

HTML

2548

Figures (1-4)

232

Sum=3218

Jun 15, 2003 (publication date) through Jan 5, 2025

Times Cited of This Article

Times Cited (37)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Jun 15, 2003; 9(6): 1302-1306
Published online Jun 15, 2003. doi: 10.3748/wjg.v9.i6.1302

Full Size Figure Download Figure

Figure 4 Cell cycle analysis. Representative flow cytometry data from QBC939 cells after 48 h in the presence of various concentration of celecoxib: 0 μmol/L (A), 10 μmol/L (B), 20 μmol/L (C) and 40 μmol/L (D). The percentage of QBC939 cells in G₀-G₁ phase after treatment with 40 μmol/L (74.66 ± 6.21) and 20 μmol/L (68.63 ± 4.36) of celecoxib increased significantly compared with control cells (t test, P < 0.01).

Citation: Wu GS, Zou SQ, Liu ZR, Tang ZH, Wang JH. Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E₂ pathway in human cholangiocarcinoma cell lines. World J Gastroenterol 2003; 9(6): 1302-1306
URL: https://www.wjgnet.com/1007-9327/full/v9/i6/1302.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i6.1302